|
May 6
|
10 Best May Dividend Stocks To Buy
|
|
May 6
|
Johnson & Johnson reports data from Phase II prostate cancer trial
|
|
May 3
|
4 Dividend Kings Poised for Growth, According to Analysts
|
|
May 3
|
30 Most Profitable Companies with Highest Margins in the World
|
|
May 3
|
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
|
|
May 3
|
Intuitive Surgical Builds On Its Robotic Surgery Prowess. But Challengers Are Coming.
|
|
May 3
|
3 Dividend Growth Stocks that Just Raised Their Payouts
|
|
May 3
|
Shareholders in Johnson & Johnson (NYSE:JNJ) are in the red if they invested three years ago
|
|
May 2
|
25 Most Profitable Companies in the US
|
|
May 2
|
Janssen-Cilag seeks expanded EMA approval for TREMFYA
|
|
May 2
|
The top pharmaceutical companies by R&D expenditure
|
|
May 2
|
Decoding Johnson & Johnson (JNJ): A Strategic SWOT Insight
|
|
May 1
|
US STOCKS-S&P 500, Nasdaq end lower after Fed rate decision, Powell press conference
|
|
May 1
|
Sector Update: Health Care Stocks Rise Late Afternoon
|
|
May 1
|
US not suffering from ‘stagflation’, says Fed chairman Jerome Powell
|
|
May 1
|
US STOCKS-S&P 500 ends lower after Fed rate decision, Powell press conference
|
|
May 1
|
Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
|
|
May 1
|
J&J Offers $6.5 Billion for Talc Lawsuits Ahead of Third Bankruptcy Filing
|
|
May 1
|
Janssen adopts J&J name as part of global rebranding effort
|
|
May 1
|
J&J Seeks Backing for $11 Billion Baby Powder Cancer Deal
|